Lantheus Holdings (LNTH) Revenue (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Revenue came in at $377.3 million in Q1 2026, up 1.23% year-on-year from $372.8 million in Q1 2025, and down 7.24% on a QoQ basis from $406.8 million in Q4 2025.
Lantheus Holdings (LNTH) Revenue (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Revenue data on file, last reported at $377.3 million in Q1 2026.
- On a quarterly basis, Revenue rose 1.23% year-over-year to $377.3 million in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 0.62% increase from a year earlier, with the FY2025 full-year figure at $1.5 billion, up 0.5% from the prior year.
- Revenue for Q1 2026 stood at $377.3 million, down from $406.8 million in the prior quarter.
- Over the last five years, Revenue for LNTH reached as high as $406.8 million in Q4 2025 and fell as low as $15.0 million in Q4 2023.
- Historically, Revenue has averaged $314.4 million across 5 years, with a median of $370.0 million in 2024.
- Across the five-year window, Revenue sank 94.3% in 2023 and jumped 2507.4% in 2024, its largest moves.
- Year by year, Revenue stood at $263.2 million in 2022, then sank by 94.3% to $15.0 million in 2023, then soared by 2507.4% to $391.1 million in 2024, then climbed by 4.01% to $406.8 million in 2025, then slipped by 7.24% to $377.3 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $377.3 million in Q1 2026, $406.8 million in Q4 2025, and $384.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Lantheus Holdings | 6.81 Bn | 6.31 Bn | 230.92 Mn | 377.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 377.33 Mn |
| Dec 31, 2025 | 406.79 Mn |
| Sep 30, 2025 | 384.01 Mn |
| Jun 30, 2025 | 378.05 Mn |
| Mar 31, 2025 | 372.76 Mn |
| Dec 31, 2024 | 391.11 Mn |
| Sep 30, 2024 | 378.73 Mn |
| Jun 30, 2024 | 394.09 Mn |
| Mar 31, 2024 | 369.98 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 319.95 Mn |
| Jun 30, 2023 | 321.70 Mn |
| Mar 31, 2023 | 300.78 Mn |
| Dec 31, 2022 | 263.17 Mn |
| Sep 30, 2022 | 239.29 Mn |
| Jun 30, 2022 | 223.72 Mn |
| Mar 31, 2022 | 208.88 Mn |
| Dec 31, 2021 | 129.56 Mn |
| Sep 30, 2021 | 102.07 Mn |
| Jun 30, 2021 | 101.06 Mn |